These authors assessed the utility of topical thrombin in TSA, and compared the effectiveness of topical thrombin to intravenous tranexamic acid.
They queried an institutional database to identify 283 patients having primary anatomic shoulder arthroplasty.
Hemoglobin loss (Hgb-loss) was calculated by the following equation: (k1 x Height^3 + k2 x Weight + k3) x (Hgb-initial – Hgb-end) x 0.001 + Hgb-transfused, where k1 = 0.3669 or 0.3561, k2 = 0.03219 or 0.03308, and k3 = 0.6041 or 0.1833 for males and females, respectively.
The authors concluded that topical thrombin is an effective adjunct to reduce blood loss and transfusion risk after total shoulder arthroplasty (TSA) and a reasonable intraoperative alternative for TXA for patients with contraindication to IV TXA.
We have a new set of shoulder youtubes about the shoulder, check them out at this link.
Use the "Search" box to the right to find other topics of interest to you.